Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1991 Apr;138(4):983–990.

Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.

G F Murphy 1, D Whitaker 1, J Sprent 1, R Korngold 1
PMCID: PMC1886107  PMID: 1901455

Abstract

The precise identity of effector mononuclear cells capable of eliciting acute graft-versus-host disease (AGVHD) is controversial. In this study, highly purified subsets of donor T cells were used to produce AGVHD to multiple minor histocompatibility (H) antigens in two strain combinations of mice matched for the major histocompatibility complex (MHC). In the C3H.SW- greater than B6 strain combination, only CD8+ effector cells produced histologic evidence of AGVHD in skin and liver, which peaked 3 weeks after transplant. In the B10.D2- greater than DBA/2 strain combination, CD4+ effector cells, and to a lesser extent, CD8+ cells, mediated disease in skin, liver, and intestine, which peaked during the fourth week after transplant. Analysis of skin and liver from both combinations showed target cell injury that was phenotypically similar and resembled that previously described in human disease in other studies. In addition, prominent epithelial injury also was detected in oropharyngeal mucosa, esophagus, hepatobiliary ducts, and seminal vesicle in both transplant settings. These findings indicate that functionally different subsets of donor T cells may be capable of initiating common pathways of cellular injury in selected target sites in AGVHD, and have potential implications for strategies that seek to ablate disease development by manipulation of donor marrow before transplantation.

Full text

PDF
983

Images in this article

987Figure 2
on p.987
988Figure 3
on p.988
989Figure 4
on p.989

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal B. B., Eessalu T. E., Hass P. E. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature. 1985 Dec 19;318(6047):665–667. doi: 10.1038/318665a0. [DOI] [PubMed] [Google Scholar]
  2. Bruce J., Symington F. W., McKearn T. J., Sprent J. A monoclonal antibody discriminating between subsets of T and B cells. J Immunol. 1981 Dec;127(6):2496–2501. [PubMed] [Google Scholar]
  3. Ceredig R., Lowenthal J. W., Nabholz M., MacDonald H. R. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature. 1985 Mar 7;314(6006):98–100. doi: 10.1038/314098a0. [DOI] [PubMed] [Google Scholar]
  4. Charley M. R., Bangert J. L., Hamilton B. L., Gilliam J. N., Sontheimer R. D. Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns. J Invest Dermatol. 1983 Nov;81(5):412–417. doi: 10.1111/1523-1747.ep12522551. [DOI] [PubMed] [Google Scholar]
  5. Cohen J. Cytokines as mediators of graft-versus-host disease. Bone Marrow Transplant. 1988 May;3(3):193–197. [PubMed] [Google Scholar]
  6. Gallucci B. B., Shulman H. M., Sale G. E., Lerner K. G., Caldwell L. E., Thomas E. D. The ultrastructure of the human epidermis in chronic graft-versus-host disease. Am J Pathol. 1979 Jun;95(3):643–662. [PMC free article] [PubMed] [Google Scholar]
  7. Golding H., Munitz T. I., Singer A. Characterization of antigen-specific, Ia-restricted, L3T4+ cytolytic T lymphocytes and assessment of thymic influence on their self specificity. J Exp Med. 1985 Sep 1;162(3):943–961. doi: 10.1084/jem.162.3.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guy-Grand D., Vassalli P. Gut injury in mouse graft-versus-host reaction. Study of its occurrence and mechanisms. J Clin Invest. 1986 May;77(5):1584–1595. doi: 10.1172/JCI112474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hamilton B. L. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens. J Immunol. 1987 Oct 15;139(8):2511–2515. [PubMed] [Google Scholar]
  10. Harris H. W., Gill T. J., 3rd Expression of class I transplantation antigens. Transplantation. 1986 Aug;42(2):109–117. doi: 10.1097/00007890-198608000-00001. [DOI] [PubMed] [Google Scholar]
  11. Jadus M. R., Schmunk G., Djeu J. Y., Parkman R. Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator. J Immunol. 1986 Nov 1;137(9):2774–2783. [PubMed] [Google Scholar]
  12. Korngold R., Sprent J. Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex. Immunol Rev. 1983;71:5–29. doi: 10.1111/j.1600-065x.1983.tb01066.x. [DOI] [PubMed] [Google Scholar]
  13. Korngold R., Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med. 1978 Dec 1;148(6):1687–1698. doi: 10.1084/jem.148.6.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Korngold R., Sprent J. T cell subsets and graft-versus-host disease. Transplantation. 1987 Sep;44(3):335–339. doi: 10.1097/00007890-198709000-00002. [DOI] [PubMed] [Google Scholar]
  15. Korngold R., Sprent J. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med. 1987 Jun 1;165(6):1552–1564. doi: 10.1084/jem.165.6.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moore R. H., Lampert I. A., Chia Y., Aber V. R., Cohen J. Effect of immunization with Escherichia coli J5 on graft-versus-host disease induced by minor histocompatibility antigens in mice. Transplantation. 1987 Aug;44(2):249–253. doi: 10.1097/00007890-198708000-00015. [DOI] [PubMed] [Google Scholar]
  17. Mowat A. M., Sprent J. Induction of intestinal graft-versus-host reactions across mutant major histocompatibility antigens by T lymphocyte subsets in mice. Transplantation. 1989 May;47(5):857–863. doi: 10.1097/00007890-198905000-00022. [DOI] [PubMed] [Google Scholar]
  18. Okuno T., Takagaki Y., Pluznik D. H., Djeu J. Y. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering. J Immunol. 1986 Jun 15;136(12):4652–4658. [PubMed] [Google Scholar]
  19. Piguet P. F., Grau G. E., Allet B., Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med. 1987 Nov 1;166(5):1280–1289. doi: 10.1084/jem.166.5.1280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rappaport H., Khalil A., Halle-Pannenko O., Pritchard L., Dantchev D., Mathé G. Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers. Am J Pathol. 1979 Jul;96(1):121–142. [PMC free article] [PubMed] [Google Scholar]
  21. Sarmiento M., Glasebrook A. L., Fitch F. W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol. 1980 Dec;125(6):2665–2672. [PubMed] [Google Scholar]
  22. Skoskiewicz M. J., Colvin R. B., Schneeberger E. E., Russell P. S. Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med. 1985 Nov 1;162(5):1645–1664. doi: 10.1084/jem.162.5.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sprent J., Webb S. R. Function and specificity of T cell subsets in the mouse. Adv Immunol. 1987;41:39–133. doi: 10.1016/s0065-2776(08)60030-9. [DOI] [PubMed] [Google Scholar]
  24. Steffen M., Abboud M., Potter G. K., Yung Y. P., Moore M. A. Presence of tumour necrosis factor or a related factor in human basophil/mast cells. Immunology. 1989 Mar;66(3):445–450. [PMC free article] [PubMed] [Google Scholar]
  25. Thueson D. O., Speck L. S., Lett-Brown M. A., Grant J. A. Histamine-releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human mononuclear cells. J Immunol. 1979 Aug;123(2):626–632. [PubMed] [Google Scholar]
  26. Von Boehmer H., Turton K. Autonomously proliferating K/D-restricted cytolytic T cell clones. Eur J Immunol. 1983 Feb;13(2):176–179. doi: 10.1002/eji.1830130216. [DOI] [PubMed] [Google Scholar]
  27. Young J. D., Liu C. C., Butler G., Cohn Z. A., Galli S. J. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9175–9179. doi: 10.1073/pnas.84.24.9175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. von Boehmer H., Shortman K. The separation of different cell classes from lymphoid organs. IX. A simple and rapid method for removal of damaged cells from lymphoid cell suspensions. J Immunol Methods. 1973 Apr;2(3):293–301. doi: 10.1016/0022-1759(73)90055-0. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES